Home › Companies › Akero Therapeutics, Inc.
How asset managers voted at Akero Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Akero Therapeutics, Inc. | 4 | 274 |
| 2024-2025 | Akero Therapeutics, Inc. | 4 | 253 |
| 2023-2024 | AKERO THERAPEUTICS INC. | 6 | 206 |
Earlier seasons list this company under the name AKERO THERAPEUTICS INC., as its holders filed it.
Explore Akero Therapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built October 14, 2026.